StocksFin Logo
AxoGen, Inc. country of incorporation
|
|
Ms. Karen Zaderej
|
428 employees
NASDAQ | Healthcare | Medical Devices
ADMA Biologics, Inc. country of incorporation
|
|
Mr. Adam Grossman
|
527 employees
NASDAQ | Healthcare | Biotechnology
Q322 reported Nov 8, 2022 Reporting Period
$36.96M 18.4% vs. Q321 Revenues Q322
83.29% 0.1% vs. Q321 Gross Profit Margin
-11.68% ! 48.9% vs. Q321 Net Profit Margin
-5.24M ! -1292.3% vs. Q321 Free Cash Flow Q322
$-0.1 ! 41.2% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Q322 reported Nov 9, 2022 Reporting Period
$41.09M 98.7% vs. Q321 Revenues Q322
23.5% 1161.3% vs. Q321 Gross Profit Margin
-36.26% ! 57.7% vs. Q321 Net Profit Margin
-45.52M ! -239.4% vs. Q321 Free Cash Flow Q322
$-0.08 ! 41.5% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Loading...
Loading...
Ratios
As of
Sep 30, 2022
Sep 30, 2022
Quick Ratio
3.16
1.26
Current Ratio
4.35
5.04
Cash Ratio
0.61
0.79
Price to Book
4.96
4.75
Price to Sales
13.62
11.61
Price to Earnings
-29.14
-8.01